JWD Subscribe to eTOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Wildlife Diseases, 33(2), 1997, pp. 261-266
© Wildlife Disease Association  1997
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schumacher, I.
Right arrow Articles by Klein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, I.
Right arrow Articles by Klein, P.

Relationship between clinical signs of upper respiratory tract disease and antibodies to Mycoplasma agassizii in desert tortoises from Nevada

IM Schumacher, DB Hardenbrook, MB Brown, ER Jacobson, and PA Klein


ABSTRACT

Plasma samples collected in 1990 from free-ranging desert tortoises (Gopherus agassizii) with and without clinical signs of upper respiratory tract disease (URTD) from Las Vegas Valley, Clark County, Nevada (USA), were tested by enzyme-linked immunosorbent assay (ELISA) for antibodies to Mycoplasma agassizii, a causative agent of URTD. The relationship between clinical signs and ELISA test results was evaluated. Of the 144 tortoises tested, 45 (31%) had clinical signs while 72 (50%) were seropositive. Presence of clinical signs of URTD was positively related to positive ELISA results (P < 0.0001) regardless of sex or age of the animal. Eighty-four percent of animals with clinical signs tested seropositive. Mucous nasal discharge, the most severe and obvious of the clinical signs, was highly predictive for exposure to M. agassizii based on the ELISA. Ninety-three percent of tortoises with mucous nasal discharge tested seropositive. Serologic testing for M. agassizii antibodies supported clinical signs as useful indicators of URTD, but it also detected potential subclinical infection in 34 (34%) of 99 animals without clinical signs.


This article has been cited by other articles:


Home page
 CVIHome page
L. D. Wendland, L. A. Zacher, P. A. Klein, D. R. Brown, D. Demcovitz, R. Littell, and M. B. Brown
Improved Enzyme-Linked Immunosorbent Assay To Reveal Mycoplasma agassizii Exposure: a Valuable Tool in the Management of Environmentally Sensitive Tortoise Populations
Clin. Vaccine Immunol., September 1, 2007; 14(9): 1190 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 J Wildl DisHome page
V. M. Dickinson, I. M. Schumacher, J. L. Jarchow, T. Duck, and C. R. Schwalbe
Mycoplasmosis in Free-ranging Desert Tortoises in Utah and Arizona
J. Wildl. Dis., October 1, 2005; 41(4): 839 - 842.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. B. Brown, G. S. McLaughlin, P. A. Klein, B. C. Crenshaw, I. M. Schumacher, D. R. Brown, and E. R. Jacobson
Upper Respiratory Tract Disease in the Gopher Tortoise Is Caused by Mycoplasma agassizii
J. Clin. Microbiol., July 1, 1999; 37(7): 2262 - 2269.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Wildlife Disease Association.